|1.||Dubey, Praveen K: 2 articles (09/2010 - 06/2010)|
|2.||Singodia, Deepak: 2 articles (09/2010 - 06/2010)|
|3.||Vyas, S P: 2 articles (09/2010 - 06/2010)|
|4.||Hu, Jia: 2 articles (08/2007 - 01/2005)|
|5.||Zhang, Yongxue: 2 articles (08/2007 - 01/2005)|
|6.||Lan, Xiaoli: 2 articles (08/2007 - 01/2005)|
|7.||Hojo, K: 2 articles (04/2001 - 01/2000)|
|8.||Kamada, H: 2 articles (04/2001 - 01/2000)|
|9.||Maeda, M: 2 articles (04/2001 - 01/2000)|
|10.||Mayumi, T: 2 articles (04/2001 - 01/2000)|
|1.||Neoplasm Metastasis (Metastasis)
08/01/1999 - "In the present study, we investigated whether the multimeric YIGSR peptide (Ac-Y16) has an antiproliferative effect and/or prevents the metastasis of human pre-B acute lymphoblastic leukaemia cells (NALM6) in severe combined immune deficient (SCID) mice. "
01/01/2011 - "In an experimental lung metastases model, following i.v. administration the YIGSR-NPs targeted the cancerous metastatic cells in lungs, with nearly no targeting to the healthy lung cells. "
11/01/2002 - "RGDS, RGDV, and RGDF were used for the structural modification of YIGSR and YIGSK, the sequences involved in the development of metastasis disease. "
08/01/1999 - "These data suggest that the multimeric YIGSR peptide can inhibit the tumour growth and metastasis of leukaemic cells and may be useful as a potential therapeutic reagent for leukaemic infiltrations."
03/01/1996 - "It was concluded that the multimeric YIGSR-containing peptide, Ac-Y16, inhibits angiogenesis, tumour growth and experimental metastasis more than the monomeric form and that it is active when administered i.p., iv. and s.c."
01/01/2014 - "Tumor growth was decreased in mice treated with YIGSR-displaying phages. "
12/01/1997 - "Although extensive research is still required, the peptide YIGSR can be considered as a basis for the development of a receptor specific radiopharmaceutical useful for the in vivo estimation of the metastatic potential of tumors. "
12/01/1997 - "The radiolabeled peptide YIGSR was detected by microscopic autoradiography on the surface of certain tumor cells, but not on the surface of any normal cell. "
08/01/1993 - "The YIGSR-non-adherent cells formed fewer lung colonies and smaller subcutaneous tumors. "
08/01/1993 - "YIGSR does not effect cell arrest but does inhibit angiogenesis which is necessary for tumor growth. "
|3.||Melanoma (Melanoma, Malignant)
06/01/2010 - "YIGSR-SL was very effective in regression of tumors in BALB/c mice bearing B16F10 melanoma cells. "
03/01/1999 - "The product was treated with CHCl2CO2H to afford the desired conjugate, Ac-Tyr-Ile-Gly-Ser-Arg-beta Ala-chitosan, which proved to inhibit the experimental lung metastasis of B16BL6 melanoma cells in mice at lower doses than the parent peptide."
02/01/1994 - "When coated on a polystyrene surface, the YIGSR-grafted tSPA (YIGSR-tSPA) promoted attachment and spreading of mouse melanoma and human rhabdomyosarcoma cells, but not of hamster fibroblasts. "
08/01/1993 - "YIGSR-adherent cells established after 30 successive selections on YIGSR-coated dishes in vitro formed more lung colonies after intravenous injection and larger tumors after subcutaneous injection than the parent B16F10 melanoma cells. "
11/02/1999 - "Polyvinyl pyrrolidone (PVP) which can be radically synthesized and have a long blood residency was used to modify the laminin-related peptide YIGSR, and its inhibitory effect on experimental lung metastasis of B16-BL6 melanoma cells was examined. "
11/01/2004 - "Using NB2a neuroblastoma cells, we found that native alginate elicited minimal cell attachment ( approximately 1.5%); however, YIGSR-alginate conjugate elicited a fivefold increase in numbers of cells attached using peptide ratios of 0.5 and 1 mg/g alginate, ranging from 9.5% of the cells at the lower ratio, to about 44% at the higher. "
06/02/1995 - "Down-regulation of a 67-kDa YIGSR-binding protein upon differentiation of human neuroblastoma cells."
03/13/1998 - "We have examined the mechanism of signaling by the 67 kDa YIGSR binding protein of laminin and its properties in neuroblastoma cells. "
06/01/1995 - "In this study, cell attachment to fluorinated ethylene propylene (FEP) films functionalized with the laminin-derived oligopeptides, YIGSR and a 19-mer IKVAV-containing sequence, was assessed using NG108-15 neuroblastoma and PC12 cells. "
|5.||Prostatic Neoplasms (Prostate Cancer)